1 |
Sardari D, Verga N, Saidi P. Estimation of the radioactivity produced in patient tissue during carbon ion therapy. Mod Appl Sci 2010;4:26-8.
|
2 |
Pshenichnov I, Mishustin I, Greiner W. Distributions of positron-emitting nuclei in proton and carbon-ion therapy studied with GEANT4. Phys Med Biol 2006;51:6099-112.
DOI
ScienceOn
|
3 |
Crespo P, Shakirin G, Enghardt W. On the detector arrangement for in-beam PET for hadron therapy monitoring. Phys Med Biol 2006;51:2143-63.
DOI
ScienceOn
|
4 |
Zirkle RE, Tobias CA. Effects of ploidy and linear energy transfer on radiobiological survival curves. Arch Biochem Biophys 1953;47:282-306.
DOI
ScienceOn
|
5 |
Chatterjee A, Schaefer HJ. Microdosimetric structure of heavy ion tracks in tissue. Radiat Environ Biophys 1976;13:215-27.
DOI
ScienceOn
|
6 |
Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 410-11.
|
7 |
Yousif A, Bahari IB, Yasir MS. Physical quality parameters affect charged particles effectiveness at lower doses. World Appl Sci J 2010;11:1225-9.
|
8 |
Mairani A. Nucleus-nucleus interaction modelling and applications in ion therapy treatment planning. Sci Acta 2007;1:129-32.
|
9 |
Enghardt W, Fromm WD, Manfrass P, Schardt D. Limited-angle 3D reconstruction of PET images for dose localization in light ion tumour therapy. Phys Med Biol 1992;37:791-8.
DOI
ScienceOn
|
10 |
Ponisch F, Parodi K, Hasch BG, Enghardt W. The modelling of positron emitter production and PET imaging during carbon ion therapy. Phys Med Biol 2004;49:5217-32.
DOI
ScienceOn
|
11 |
Watanabe R, Wada S, Funayama T, Kobayashi Y, Saito K, Furusawa Y. Monte Carlo simulation of radial distribution of DNA strand breaks along the C and Ne ion paths. Radiat Prot Dosimetry 2011;143:186-90.
DOI
|
12 |
Paganetti H, Goitein M. Radiobiological significance of beamline dependent proton energy distributions in a spreadout Bragg peak. Med Phys 2000;27:1119-26.
DOI
ScienceOn
|
13 |
Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413-26.
DOI
|
14 |
Robertson JB, Williams JR, Schmidt RA, Little JB, Flynn DF, Suit HD. Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer 1975;35:1664-77.
DOI
ScienceOn
|
15 |
Elsasser T, Kramer M, Scholz M. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys 2008;71:866-72.
DOI
ScienceOn
|
16 |
Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy: the model and its approximation. Radiat Environ Biophys 1997;36:59-66.
DOI
ScienceOn
|
17 |
Hoglund E, Blomquist E, Carlsson J, Stenerlow B. DNA damage induced by radiation of different linear energy transfer: initial fragmentation. Int J Radiat Biol 2000;76:539-47.
DOI
ScienceOn
|
18 |
Lobrich M, Cooper PK, Rydberg B. Non-random distribution of DNA double-strand breaks induced by particle irradiation. Int J Radiat Biol 1996;70:493-503.
DOI
ScienceOn
|
19 |
Ballarini F, Alloni D, Facoetti A, Ottolenghi A. Heavy-ion effects: from track structure to DNA and chromosome damage. New J Phys 2008;10:1-17.
|
20 |
Ares C, Hug EB, Lomax AJ, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: fi rst long-term report. Int J Radiat Oncol Biol Phys 2009;75:1111-8.
DOI
ScienceOn
|
21 |
Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 1994;65:7-17.
DOI
ScienceOn
|
22 |
Taddei PJ, Mahajan A, Mirkovic D, et al. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol 2010;55:7067-80.
DOI
ScienceOn
|
23 |
Scholz M, Matsufuji N, Kanai T. Test of the local effect model using clinical data: tumour control probability for lung tumours after treatment with carbon ion beams. Radiat Prot Dosimetry 2006;122:478-9.
DOI
|
24 |
Jiang H, Wang B, Xu XG, Suit HD, Paganetti H. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol 2005;50:4337-53.
DOI
ScienceOn
|
25 |
Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, DC: National Academy Press; 2006.
|
26 |
Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1-7.
DOI
ScienceOn
|
27 |
Schaffner B, Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: experimental verifi cation of the relation between CT-HU and proton stopping power. Phys Med Biol 1998;43:1579-92.
DOI
ScienceOn
|
28 |
Gottschalk B. Neutron dose in scattered and scanned proton beams: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 2006;66:1594.
|
29 |
Wang D, Mackie TR, Tome WA. Bragg peak prediction from quantitative proton computed tomography using different path estimates. Phys Med Biol 2011;56:587-99.
DOI
ScienceOn
|
30 |
Grassberger C, Trofi mov A, Lomax A, Paganetti H. Variations in linear energy transfer within clinical proton therapy fi elds and the potential for biological treatment planning. Int J Radiat Oncol Biol Phys 2011;80:1559-66.
DOI
ScienceOn
|
31 |
Penfold SN, Rosenfeld AB, Schulte RW, Schubert KE. A more accurate reconstruction system matrix for quantitative proton computed tomography. Med Phys 2009;36:4511-8.
DOI
ScienceOn
|
32 |
Amaldi U. Hadrontherapy in the world and the programmes of the TERA Foundation. Tumori 1998;84:188-99.
|
33 |
Hirao Y, Ogawa H, Yamada S, et al. Heavy ion synchrotron for medical use: HIMAC project at NIRS-Japan. Nuclear Physics A 1992;538:541-50.
DOI
|
34 |
Particle Therapy Co-operative Group. Particle therapy facilities in a planning stage or under construction [Internet]. Particle Therapy Co-operative Group; 2011 [cited 2011 Mar 20]. Available from: http://ptcog.web.psi.ch/newptcentres.html.
|
35 |
Jermann M. Patient statistics per end of 2010: Hadron therapy patient statistics. Particle Therapy Co-Operative Group; 2011 [cited 2011 Mar 20]. Available from: http://ptcog.web.psi.ch/ patient_statistics.html.
|
36 |
Khan FM. The physics of radiation therapy. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 6-7.
|
37 |
Van der Kogel AJ, Joiner MC. Basic clinical radiobiology. 4th ed. London, UK: Hodder Arnold; 2009. p. 68.
|
38 |
Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol (R Coll Radiol) 2003;15:S37-50.
DOI
ScienceOn
|
39 |
International Commission on Radiation Units and Measurements (ICRU). Tissue substitutes in radiation dosimetry and measurement. ICRU Report 44. Bethesda, MD: ICRU Pub.; 1989.
|
40 |
Matsuzaki Y, Date H, Sutherland KL, Kiyanagi Y. Nuclear collision processes around the Bragg peak in proton therapy. Radiol Phys Technol 2010;3:84-92.
DOI
ScienceOn
|
41 |
Uehara S, Toburen LH, Wilson WE, Goodhead DT, Nikjoo H. Calculations of electronic stopping cross sections for lowenergy protons in water. Radiat Phys Chem 2000;59:1-11.
DOI
ScienceOn
|
42 |
National Institute of Standards and Technology. Stopping power and range tables for protons [Internet]. Gaithersburg, MD: National Institute of Standards and Technology; 2011 [cited 2011 Jun 20]. Available from: http://physics.nist.gov/ PhysRefData/Star/Text/PSTAR.html.
|
43 |
International Commission on Radiation Units and Measurements (ICRU). Stopping powers for protons and alpha particles. ICRU Report 49. Bethesda, MD: ICRU Pub.; 1993.
|
44 |
International Commission on Radiation Units and Measurements (ICRU). Nuclear data for neutron and proton radiotherapy and for radiation protection. ICRU Report 63. Bethesda, MD: ICRU Pub.; 2000.
|
45 |
Dingfelder M, Inokuti M, Paretzke HG. Inelastic-collision cross sections of liquid water for interactions of energetic protons. Radiat Phys Chem 2000;59:255-75.
DOI
ScienceOn
|
46 |
National Research Council. Studies in penetration of charged particles in matter. Nuclear science series report 39. Washington, DC: National Academy of Sciences-National Research Council; 1964.
|
47 |
Nikjoo H, Goodhead DT. Track structure analysis illustrating the prominent role of low-energy electrons in radiobiological effects of low-LET radiations. Phys Med Biol 1991;36:229-38.
DOI
ScienceOn
|
48 |
Paganetti H. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. Phys Med Biol 2002;47:747-64.
DOI
ScienceOn
|
49 |
The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
|
50 |
Lyman JT, Awschalom M, Berardo P, et al. Protocol for heavy charged-particle therapy beam dosimetry: a report of Task Group 20 Radiation Therapy Committee American Association of Physicists in Medicine. AAPM Report 16. New York, NY: American Institute of Physics for the American Association of Physicists in Medicine; 1986.
|
51 |
Bichsel H, Hiraoka T, Omata K. Aspects of fast-ion dosimetry. Radiat Res 2000;153:208-19.
DOI
ScienceOn
|